Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
NCT00004396 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2005-06-24
Summary
OBJECTIVES: I. Compare the efficacy of heme arginate, singly or in combination with tin mesoporphyrin, in lowering porphyrin precursors in patients with asymptomatic acute intermittent porphyria.
II. Evaluate and compare the safety and tolerability of these treatment regimens in this patient population.
Conditions
- Porphyria
Interventions
- DRUG
-
heme arginate
- DRUG
-
tin mesoporphyrin
Sponsors & Collaborators
-
University of Texas
collaborator OTHER -
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Karl Elmo Anderson · University of Texas
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-09-30
Countries
- United States
Study Locations
More Related Trials
-
Panhematin for Prevention of Acute Attacks of Porphyria
NCT02922413 ·Status: TERMINATED ·Phase: PHASE2
-
Longitudinal Study of the Porphyrias
NCT01561157 ·Status: RECRUITING
-
Study of the Pathogenesis of Porphyria Cutanea Tarda
NCT00005103 ·Status: COMPLETED
-
Study of Nutritional Factors in Porphyria
NCT00004788 ·Status: COMPLETED
-
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
NCT00004381 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria
NCT02180412 ·Status: COMPLETED ·Phase: PHASE2
-
Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria
NCT03906214 ·Status: COMPLETED
-
Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
NCT01688895 ·Status: COMPLETED
-
Oral Iron for Erythropoietic Protoporphyrias
NCT02979249 ·Status: COMPLETED ·Phase: NA
-
Diagnostic of Iron Deficiency by Means of Non Invasive Measurement of Zink Protoporphyrin IX
NCT03231865 ·Status: COMPLETED
-
Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer
NCT01019096 ·Status: COMPLETED
-
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 ·Status: COMPLETED
-
Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
NCT00004940 ·Status: COMPLETED ·Phase: PHASE3
-
A Stratified Sickle Event Randomized Trial (ASSERT)
NCT00102791 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria
NCT01550705 ·Status: TERMINATED ·Phase: NA
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia
NCT00006136 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
NCT00004831 ·Status: COMPLETED ·Phase: NA
-
Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
NCT04253626 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
NCT05210790 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
NCT01000155 ·Status: TERMINATED ·Phase: PHASE2
-
Porphozym in the Treatment of Acute Attacks in AIP
NCT00418795 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))
NCT01880983 ·Status: COMPLETED
-
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
NCT02957643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hemochromatosis--Genetic Prevalence and Penetrance
NCT00006312 ·Status: COMPLETED